Owens & Minor ROA 2010-2025 | OMI
Current and historical return on assets (ROA) values for Owens & Minor (OMI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Owens & Minor ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $-0.37B | $4.86B | -7.36% |
| 2024-12-31 | $-0.36B | $4.66B | -7.17% |
| 2024-09-30 | $-0.05B | $5.08B | -0.95% |
| 2024-06-30 | $-0.04B | $5.30B | -0.81% |
| 2024-03-31 | $-0.04B | $5.21B | -0.73% |
| 2023-12-31 | $-0.04B | $5.09B | -0.77% |
| 2023-09-30 | $-0.12B | $5.12B | -2.20% |
| 2023-06-30 | $-0.10B | $5.29B | -1.82% |
| 2023-03-31 | $-0.04B | $5.31B | -0.75% |
| 2022-12-31 | $0.02B | $5.39B | 0.40% |
| 2022-09-30 | $0.12B | $5.54B | 2.40% |
| 2022-06-30 | $0.15B | $5.56B | 3.35% |
| 2022-03-31 | $0.19B | $5.71B | 4.65% |
| 2021-12-31 | $0.22B | $3.54B | 6.30% |
| 2021-09-30 | $0.23B | $3.58B | 6.65% |
| 2021-06-30 | $0.23B | $3.59B | 6.84% |
| 2021-03-31 | $0.11B | $3.39B | 3.37% |
| 2020-12-31 | $0.03B | $3.34B | 0.89% |
| 2020-09-30 | $-0.06B | $3.30B | -1.74% |
| 2020-06-30 | $-0.11B | $3.14B | -2.96% |
| 2020-03-31 | $-0.06B | $3.72B | -1.58% |
| 2019-12-31 | $-0.06B | $3.64B | -1.64% |
| 2019-09-30 | $-0.28B | $3.69B | -7.45% |
| 2019-06-30 | $-0.29B | $3.90B | -7.34% |
| 2019-03-31 | $-0.46B | $3.88B | -11.67% |
| 2018-12-31 | $-0.44B | $3.77B | -11.47% |
| 2018-09-30 | $-0.15B | $4.03B | -4.12% |
| 2018-06-30 | $-0.14B | $4.04B | -3.99% |
| 2018-03-31 | $0.06B | $3.39B | 1.92% |
| 2017-12-31 | $0.07B | $3.38B | 2.39% |
| 2017-09-30 | $0.08B | $3.33B | 2.67% |
| 2017-06-30 | $0.10B | $2.80B | 3.49% |
| 2017-03-31 | $0.10B | $2.70B | 3.76% |
| 2016-12-31 | $0.11B | $2.72B | 3.90% |
| 2016-09-30 | $0.11B | $2.80B | 4.06% |
| 2016-06-30 | $0.11B | $2.76B | 4.01% |
| 2016-03-31 | $0.11B | $2.80B | 3.89% |
| 2015-12-31 | $0.10B | $2.77B | 3.74% |
| 2015-09-30 | $0.09B | $2.75B | 3.10% |
| 2015-06-30 | $0.06B | $2.80B | 2.29% |
| 2015-03-31 | $0.06B | $2.70B | 2.23% |
| 2014-12-31 | $0.07B | $2.74B | 2.54% |
| 2014-09-30 | $0.08B | $2.94B | 3.20% |
| 2014-06-30 | $0.10B | $2.36B | 4.30% |
| 2014-03-31 | $0.11B | $2.37B | 4.67% |
| 2013-12-31 | $0.11B | $2.32B | 4.74% |
| 2013-09-30 | $0.11B | $2.35B | 4.66% |
| 2013-06-30 | $0.10B | $2.38B | 4.55% |
| 2013-03-31 | $0.11B | $2.32B | 4.82% |
| 2012-12-31 | $0.11B | $2.21B | 5.19% |
| 2012-09-30 | $0.11B | $2.22B | 5.32% |
| 2012-06-30 | $0.12B | $1.96B | 5.97% |
| 2012-03-31 | $0.12B | $1.93B | 5.95% |
| 2011-12-31 | $0.11B | $1.95B | 5.91% |
| 2011-09-30 | $0.11B | $1.95B | 5.90% |
| 2011-06-30 | $0.11B | $1.91B | 5.88% |
| 2011-03-31 | $0.11B | $1.91B | 5.96% |
| 2010-12-31 | $0.11B | $1.82B | 6.10% |
| 2010-09-30 | $0.12B | $1.84B | 6.78% |
| 2010-06-30 | $0.12B | $1.81B | 7.09% |
| 2010-03-31 | $0.12B | $1.75B | 6.92% |
| 2009-12-31 | $0.11B | $1.75B | 6.16% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.669B | $10.701B |
| Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.616B | 27.97 |
| Boston Scientific (BSX) | United States | $153.611B | 38.46 |
| Stryker (SYK) | United States | $149.817B | 31.33 |
| EssilorLuxottica (ESLOY) | France | $128.259B | 0.00 |
| Medtronic (MDT) | Ireland | $112.441B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.320B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.596B | 26.03 |
| ResMed (RMD) | United States | $37.597B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.163B | 16.22 |
| Agilent Technologies (A) | United States | $33.875B | 22.08 |
| Terumo (TRUMY) | Japan | $24.770B | 32.17 |
| Koninklijke Philips (PHG) | Netherlands | $22.956B | 16.11 |
| Insulet (PODD) | United States | $21.162B | 83.07 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.315B | 11.76 |
| Baxter (BAX) | United States | $15.236B | 11.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.113B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $3.900B | 17.42 |
| Perrigo (PRGO) | Ireland | $3.676B | 9.32 |
| Haemonetics (HAE) | United States | $3.609B | 16.44 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.192B | 23.54 |
| QuidelOrtho (QDEL) | United States | $1.976B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.875B | 41.91 |
| AtriCure (ATRC) | United States | $1.561B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
| Phibro Animal Health (PAHC) | United States | $1.212B | 15.49 |
| Green Thumb Industries (GTBIF) | United States | $1.163B | 26.16 |
| Neogen (NEOG) | United States | $1.081B | 13.83 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| InMode (INMD) | Israel | $0.954B | 9.62 |
| Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
| CeriBell (CBLL) | United States | $0.622B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.507B | 0.00 |
| Valneva SE (VALN) | France | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Surmodics (SRDX) | United States | $0.424B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.344B | 12.67 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| Quanterix (QTRX) | United States | $0.315B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| ZimVie (ZIMV) | United States | $0.263B | 11.94 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Brainsway (BWAY) | Israel | $0.253B | 66.85 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
| Cresco Labs (CRLBF) | United States | $0.247B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.186B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.13 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 15.90 |
| Apyx Medical (APYX) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.070B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.29 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.10 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |